Type 2 Diabetics needed for research study


14815

Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Renal Blood Flow and its Correlation with Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease Compared to Healthy Volunteers (KXK005)

Medicine

Kalantari Kambiz,

The Nephrology Clinical Research Center at the University of Virginia is looking for men and women ages 40 to 75 to participate in a research study. If you are a type 2 diabetic and currently taking a medicine to also treat high blood pressure then you may be eligible to participate. We are looking for diabetics who are currently on a certain type of blood pressure medicine know as ACE inhibitors(angiotensin-converting enzyme inhibitors) or ARB (angiotensin receptor blockers). These types of drugs have been shown to protect the kidneys in diseases such as diabetes by reducing the amount of protein that is lost in the urine. We are interested to know how much of the protective effect of these types of drugs is due to changing the flow of blood to the kidney. In this study we will compare blood flow to the kidneys in healthy people that do not have diabetes or kidney disease with people that have diabetes and evidence of kidney disease. If you do not have any medical problems then you may qualify for this study. Qualified study participants will receive: Study related Physical Exams Laboratory testing Electrocardiogram (ECG) - Recording of the activity of the heart over time. Contrast enhanced ultrasound of your kidney and heart Compensation for time and travel of up to $150.00 For more information and to see if you qualify, please call the Nephrology Clinical Research Center at 924-5820. IRB-HSR #14815 Principal Investigator: Kambiz Kalantarinia, MD


Adult

Kidney Disease

Nephrology (Kidney)

Ill

No Compensation

Sharon (Lisa) Johnson

sfj8n@virginia.edu

4349245820